ASX
Imugene Limited
IMU:ASX•Healthcare
Sensitive ASX Announcement
FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
Published: 13/12/21, 08:47am (AEST)•3 pages